Predictors and Molecular Epidemiology of Community-Onset Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in a Midwestern Community

Dogs of Nomadic Pastoralists in Northern Kenya Are Reservoirs of Plasmid-Mediated Cephalosporin- and Quinolone-Resistant Escherichia coli, Including Pandemic Clone B2-O25-ST131

(2012) Katerina Albrechtova et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Occurrence and characteristics of extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae in food producing animals, minced meat and raw milk

(2012) Nadine Geser et al.   BMC Veterinary Research

Community-Associated Extended-Spectrum β-Lactamase–Producing Escherichia coli Infection in the United States

(2012) Yohei Doi et al.   CLINICAL INFECTIOUS DISEASES

No NDM-1 carriage in healthy persons from Mumbai: reassuring for now

(2012) P. Deshpande et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Identification of extended-spectrum  -lactamase and quinolone resistance genes in Escherichia coli isolated from hospital wastewater from central India

(2012) V. Diwan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae in International Travelers and Non-Travelers in New York City

(2012) Scott A. Weisenberg et al.   PLoS One

Variation in the genetic environments of blaCTX-M-15 in Escherichia coli from the faeces of travellers returning to the United Kingdom

(2011) H. Dhanji et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents

(2011) Monika Dolejska et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemiology and Risk Factors of Community Onset Infections Caused by Extended-Spectrum  -Lactamase-Producing Escherichia coli Strains

(2011) C.-I. Kang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Mortality and Hospital Stay Associated with Resistant Staphylococcus aureus and Escherichia coli Bacteremia: Estimating the Burden of Antibiotic Resistance in Europe

(2011) Marlieke E. A. de Kraker et al.   PLOS MEDICINE

Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum  -Lactamases: a Prospective Study with Swedish Volunteers

(2010) T. Tangden et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

National Multicenter Study of Predictors and Outcomes of Bacteremia upon Hospital Admission Caused by Enterobacteriaceae Producing Extended-Spectrum  -Lactamases

(2010) D. Marchaim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Costs of Bloodstream Infections Caused by Escherichia coli and Influence of Extended-Spectrum- -Lactamase Production and Inadequate Initial Antibiotic Therapy

(2010) M. Tumbarello et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States

(2010) James R. Johnson et al.   CLINICAL INFECTIOUS DISEASES

Colonisation with Escherichia coli resistant to “critically important” antibiotics: a high risk for international travellers

(2010) K. Kennedy et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum β-lactamase-producing Escherichia coli

(2010) Cheol-In Kang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Intrafamilial transmission of extended-spectrum- -lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children

(2010) D. Tande et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers’ diarrhoea

(2010) Johan Tham et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Molecular Characteristics of Travel-Related Extended-Spectrum- -Lactamase-Producing Escherichia coli Isolates from the Calgary Health Region

(2009) J. D. D. Pitout et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004

(2009) J. R. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients

(2009) Ronen Ben‐Ami et al.   CLINICAL INFECTIOUS DISEASES

The changing epidemiology of resistance

(2009) P. M. Hawkey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Escherichia coli producing SHV-type extended-spectrum  -lactamase is a significant cause of community-acquired infection

(2009) J. Rodriguez-Bano et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High Prevalence of Plasmid-Mediated Quinolone Resistance Genes qnr and aac(6')-Ib-cr in Clinical Isolates of Enterobacteriaceae from Nine Teaching Hospitals in China

(2008) H. Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Changes in aac(6')-Ib-cr Prevalence and Fluoroquinolone Resistance in Nosocomial Isolates of Escherichia coli Collected from 1991 through 2005

(2008) G. Warburg et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli

(2008) Jesús Rodríguez-Baño et al.   ARCHIVES OF INTERNAL MEDICINE

Community‐Onset Genitourinary Tract Infection due to CTX‐M‐15–ProducingEscherichia coliamong Travelers to the Indian Subcontinent in New Zealand

(2008) Joshua T. Freeman et al.   CLINICAL INFECTIOUS DISEASES

European Emergence of Ciprofloxacin-Resistant Escherichia coli Clonal Groups O25:H4-ST 131 and O15:K52:H1 Causing Community-Acquired Uncomplicated Cystitis

(2008) S. Cagnacci et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Community-onset extended-spectrum β-lactamase (ESBL) producing Escherichia coli: Importance of international travel

(2008) Kevin B. Laupland et al.   JOURNAL OF INFECTION